Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.
about
Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virusImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsLy6 family proteins in neutrophil biologyMyeloid-derived suppressor cells as therapeutic target in hematological malignanciesCEACAM1 regulates TIM-3-mediated tolerance and exhaustionTumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Galectin-9 ameliorates Con A-induced hepatitis by inducing CD4(+)CD25(low/int) effector T-Cell apoptosis and increasing regulatory T cell number.Tim-3 and its role in regulating anti-tumor immunity.Regulation of T cell responses by the receptor molecule Tim-3.Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis.Tim-3 expression defines regulatory T cells in human tumors.Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaRecipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK CellsT cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infectionsPancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapySoluble costimulatory molecule sTim3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion.Two opposing roles of O-glycans in tumor metastasis.Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling PathwayMethamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targetsContrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretionTim-3 enhances FcεRI-proximal signaling to modulate mast cell activation.TIM-3 regulates innate immune cells to induce fetomaternal tolerance.TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells.The regulatory power of glycans and their binding partners in immunityPlasma levels of Galectin-9 reflect disease severity in malaria infection.Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondii.Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer.Tim-3: an activation marker and activation limiter of innate immune cellsGlycobiology of immune responsesGalectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsTIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.Myeloid-derived suppressor cells: a double-edged sword?Emerging Tim-3 functions in antimicrobial and tumor immunity.Molecular signatures of T-cell inhibition in HIV-1 infection.
P2860
Q24321941-5BD5EC37-4BDB-437C-AB5C-6B18A69F49AAQ26765459-3DDF6ED6-A461-4B24-881E-5C5145E0F61DQ26782799-96AD863E-4ADD-4B06-BC23-EF416D47F626Q26852085-E57CA2EB-3465-4ACA-81C7-5141682FC96AQ27010234-8C018262-51F3-435B-81AC-AC8B6B9F2DD9Q28115443-3F63E7A6-FE6B-4C91-9C18-4CE555B21CBEQ28116224-38007FC7-35F0-4C45-A8C6-A5BDCE1EFE23Q31106123-14DFE417-6B01-4090-99E3-C2DAAC65BEEFQ33909020-B3034E80-4D75-41F2-841B-5644ACB1C35BQ34017074-B228BA04-A920-499B-897B-FBC1DB98FBA2Q34462234-B40F5795-E271-4132-8EAE-D8179FB99217Q34580313-3B717337-9B45-4A07-B46F-EB3CA0B1D801Q34634058-AA381082-B773-4B84-8A1F-596CEFF2434CQ34997704-4E5E514D-810B-4862-B298-401076FCC6A0Q35108289-AEA20599-5F85-4EE5-9FF4-B6C904D3D06DQ35512538-067B1F84-731D-410F-9A5A-C6F828A50783Q35571333-4D3B5700-6662-4C1B-BB93-7F63DA21F6B0Q35801558-3A899DBE-4AC4-468A-9B8C-E047C69142BBQ35886496-FCA4429B-4077-4986-98DB-4AD43E33B285Q35958659-44A2E4DD-7169-4538-8B9B-7BDFF3B82E56Q35972468-4563324E-5CE4-4F55-98C8-6AAF5C6261DCQ35974260-E64F6471-5DE2-419F-A89C-969DBC474643Q35997428-9CC4B5E3-56FE-46E5-B220-6F4EEF988BDBQ36106330-578A6986-E3DE-4306-A1E2-7B6B803044C4Q36381148-101591D4-E159-4306-A4D5-EC0731EBD830Q36398769-C7CBA2C9-2F45-44C8-8264-AF2CE3F8DD31Q36487481-229772B8-0A07-40C6-B449-D3D4B4781353Q36595351-6678F673-92C2-4B27-8A96-19FA46945C01Q36651216-EE4AC6CD-C675-42B4-BB89-E9D4458024B1Q36906422-B159C49F-0C08-4BB6-B1AD-DF63B0F304BEQ37170129-4F3C3C9D-B715-4D83-BB2A-824261620500Q37320024-6411106C-4239-41B2-ABEE-D15A29800B78Q37368087-111DEEAC-2D3A-451A-85FC-7B151027CA82Q37379212-7BEFC7C2-5781-4237-9F74-B9DC6088FC72Q37448685-707A8FA6-9FAF-4477-8B41-44763C49B669Q37667547-91289135-0940-4CE0-BE62-174CFD95C16FQ37729313-DA635BE8-E3DF-4D93-A67A-AF117937CE97Q37840240-2201C743-5665-427A-BD7D-6A5251BBE7C4Q37893320-6FF0C9B6-D6A1-40FC-A165-D584CC459D34Q38091548-90831B52-B22A-4BF0-A185-82FAB5D6159D
P2860
Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@ast
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@en
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@nl
type
label
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@ast
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@en
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@nl
prefLabel
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@ast
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@en
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells.
@nl
P2093
P2860
P356
P1476
Tim-3/galectin-9 pathway: regu ...... of CD11b+Ly-6G+ myeloid cells
@en
P2093
Akira Yamauchi
Ana C Anderson
David H Lee
Francisco J Quintana
Jozsef Karman
Melanie Cornejo
Mitsuomi Hirashima
Raymond A Sobel
Rucha Chandwaskar
Valerie Dardalhon
P2860
P304
P356
10.4049/JIMMUNOL.0903275
P407
P577
2010-06-23T00:00:00Z